14-16 October 2026
Lisbon, Portugal
Call for abstracts will open on 27 January 2026.
Apply for oral or poster presentations.
The Champalimaud Research Symposium 2026
(CRSy26) will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.
Key topics will include mechanistic insights into neuro-immune signaling pathways, the influence of stress and innervation on tumor immunity, and how immune responses can affect neural activity within tumours and beyond.
(CRSy26) will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.
Key topics will include mechanistic insights into neuro-immune signaling pathways, the influence of stress and innervation on tumor immunity, and how immune responses can affect neural activity within tumours and beyond.
Symposium Chairs
Carlos Minutti
Immunoregulation Lab, Champalimaud Foundation, Lisbon, PT
Henrique Veiga-Fernandes Immunophysiology Lab, Champalimaud Foundation, Lisbon, PT
Carlos Minutti
Immunoregulation Lab, Champalimaud Foundation, Lisbon, PT
Henrique Veiga-Fernandes Immunophysiology Lab, Champalimaud Foundation, Lisbon, PT
Confirmed Keynote Speakers
Douglas Hanahan
EPFL, Lausanne, CH
Florent Ginhoux
Gustave Roussy, Villejuif, FR
Douglas Hanahan
EPFL, Lausanne, CH
Florent Ginhoux
Gustave Roussy, Villejuif, FR
CRSy is the main scientific symposium of the Champalimaud Research. Since 2017, it has fostered global dialogue among researchers across various disciplines, focusing on groundbreaking advancements in neuroscience, physiology and cancer.
Srini Turaga, PhD
Janelia Research Campus, Howard Hughes Medical Institute
Ashburn, Virginia, USAHe is a group leader at HHMI Janelia Research Campus and a member of the NSF AI Institute for Artificial and Natural Intelligence (ARNI). His research lies at the intersection of AI and science, with a particular focus on neuroscience, biomechanics, optics, and protein engineering. He and his team model the brain and the body to understand neural computation. They combine differentiable simulations of optical systems to develop a new kind of programmable microscope and engineer new protein sensors using machine learning and mechanistic models of protein function.
︎ Visit the speaker’s lab here